Literature DB >> 16368187

Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY.

Amedeo A Azizi1, Ellen Gelpi, Jae-Won Yang, Bernhard Rupp, Andrew K Godwin, Carolyn Slater, Irene Slavc, Gert Lubec.   

Abstract

OVCA2 is a putative serine-hydrolase. Performing protein profiling in human tumour cell lines, OVCA2 was detected in DAOY medulloblastoma cells as a high abundance protein. The protein was unambiguously identified by 2D gel-electrophoresis and MALDI-MS and MS/MS, its presence was confirmed by western blotting. Immunohistochemistry revealed expression in medulloblastoma and predominantly in oligodendrocytes. Computational approaches predicted functional motifs and domains, interaction with apoptosis-related protein BAG and 3D structure. In addition to the presence of OVCA2 in medulloblastoma, it was furthermore detectable in three out of 10 human tumour cell-lines as a high abundance protein probably suggesting a role in the tumour biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368187     DOI: 10.1016/j.canlet.2005.10.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Human OVCA2 and its homolog FSH3-induced apoptosis in Saccharomyces cerevisiae.

Authors:  Ramachandran Gowsalya; Chidambaram Ravi; Vasanthi Nachiappan
Journal:  Curr Genet       Date:  2021-03-13       Impact factor: 3.886

2.  Biochemical Characterization of a Novel α/β-Hydrolase/FSH from the White Shrimp Litopenaeus vannamei.

Authors:  Karina D Garcia-Orozco; Francisco Cinco-Moroyoqui; Lucía T Angulo-Sanchez; Enrique Marquez-Rios; Armando Burgos-Hernandez; Jose L Cardenas-Lopez; Carolina Gomez-Aguilar; David O Corona-Martinez; Gloria Saab-Rincon; Rogerio R Sotelo-Mundo
Journal:  Biomolecules       Date:  2019-10-31

3.  Comparative analysis of the human serine hydrolase OVCA2 to the model serine hydrolase homolog FSH1 from S. cerevisiae.

Authors:  Jessica S Bun; Michael D Slack; Daniel E Schemenauer; R Jeremy Johnson
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.